D016393DisordersC04.557.386.480.150C15.604.515.569.480.150C20.683.515.761.480.1509120.990877Lymphoma, B-CellFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonCancer BiologyMicrobiology and ImmunologyPathologyWake Forest School of MedicineKarenHaasKaren M. Haas PhD36.08919100000000-80.26677800000000539Haas, KarenAssociate ProfessorOmarSanguezaOmar P. Sangueza MD36.08959100000000-80.26859900000000736Sangueza, OmarProfessorYusukeShiozawaYusuke Shiozawa MD, PhD36.09032400000000-80.266491000000001731Shiozawa, YusukeAssociate Professor20ProfessorMichaelShapiroMichael D. Shapiro DO2451Shapiro, MichaelProfessor24Assistant Professor30549430Sang AX, McPherson MC, Ivison GT, Qu X, Rigdon J, Esquivel CO, Krams SM, Martinez OMAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsSang AX, McPherson MC, Ivison GT, Qu X, Rigdon J, Esquivel CO, Krams SM, Martinez OM. Dual blockade of the PI3K/Akt/mTOR pathway inhibits posttransplant Epstein-Barr virus B cell lymphomas and promotes allograft survival. Am J Transplant. 2019 05; 19(5):1305-1314.Am J Transplant2019-01-09T00:00:002019Dual blockade of the PI3K/Akt/mTOR pathway inhibits posttransplant Epstein-Barr virus B cell lymphomas and promotes allograft survival.Internal Medicine, Cardiovascular MedicineOtolaryngologyMichaelBrennanMichael T. Brennan DDS, MHS3193Brennan, MichaelClinical Professor34584212Vega F, Amador C, Chadburn A, Hsi ED, Slack G, Medeiros LJ, Feldman ALModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncVega F, Amador C, Chadburn A, Hsi ED, Slack G, Medeiros LJ, Feldman AL. Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up. Mod Pathol. 2022 Mar; 35(3):306-318.Mod Pathol2021-09-28T00:00:002021Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up.33139702Kapoor I, Bodo J, Hill BT, Hsi ED, Almasan ACell death & diseaseKapoor I, Bodo J, Hill BT, Hsi ED, Almasan A. Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance. Cell Death Dis. 2020 Nov 02; 11(11):941.Cell Death Dis2020-11-02T00:00:002020Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance.36454275Sander B, Campo E, Hsi EDVirchows Archiv : an international journal of pathologySander B, Campo E, Hsi ED. Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation. Virchows Arch. 2023 Jan; 482(1):131-145.Virchows Arch2022-12-01T00:00:002022Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation.30651281Landsburg DJ, Hughes ME, Koike A, Bond D, Maddocks KJ, Guo L, Winter AM, Hill BT, Ondrejka SL, Hsi ED, Nasta SD, Svoboda J, Schuster SJ, Bogusz AMBlood advancesLandsburg DJ, Hughes ME, Koike A, Bond D, Maddocks KJ, Guo L, Winter AM, Hill BT, Ondrejka SL, Hsi ED, Nasta SD, Svoboda J, Schuster SJ, Bogusz AM. Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapy. Blood Adv. 2019 Jan 22; 3(2):132-135.Blood Adv2019-01-22T00:00:002019Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapy.true1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Clinical ProfessorClinical Professortrue1ProfessorProfessor0.3292620.05648439research area of0.9172760.034882862subject area for